MEway Pharma develops solutions that combine nebulization and inhalation technologies in order to improve pulmonary drug delivery. The companys UltraFlow Nebulizer is a handheld nebulizer that combines fine particle emission, rapid flow rate, and a breath-actuated mechanism, enabling improved efficacy and a shorter treatment time.
Cumulative Funding Raised Over Time ($)
Employees Over Time
MEway Pharma Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Jan 27, 2016
www.fiercebiotech.com
Philips, Teva venture firm looks to invest $26M in Israeli med tech